WAR QUM …..What is it good for?. A R EVIEW OF Q UALITY U SE OF M EDICINES (QUM) P ROJECTS AT THE M ATER C HILDREN ’ S E MERGENCY D EPARTMENT.

Slides:



Advertisements
Similar presentations
Implementing the Stroke Palliative Approach Pathway
Advertisements

Overview of the Study Protocol
Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
Common/shared responsibilities between jobs.
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Medication Management
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
CQC registration for providers of Primary Dental Services Medicines Management Caroline Crouch NHS Dorset.
MEDICINES SELECTION & FORMULARY MANAGEMENT
Putting Research Evidence to Work Research Seminar 14 th January 2009.
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum MODULE 5 Take-Home Medication.
Homecare Medicines: Reducing the risks Professor Ray Fitzpatrick Clinical Director of Pharmacy Royal Wolverhampton NHS Trust Co Chair Standards and Handbook.
Brock Delfante Pharmacist Sir Charles Gairdner Hospital
Research Proposal Development of research question
Minnesota Manual of Accommodations for Students with Disabilities Training Guide
Community Planning Training 1-1. Community Plan Implementation Training 1- Community Planning Training 1-3.
Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Evaluation of Unit-based Pharmacy.
Daniel Flynn 1, Mary Kells 1, Mary Joyce 1&2, Catalina Suarez 1&2 1. Health Service Executive 2. National Suicide Research Foundation The National Dialectical.
Quality Improvement Prepeared By Dr: Manal Moussa.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Criteria and Standard.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
The Health Roundtable 4-4c_HRT1215-Session_CLARK_PCHosp_QLD TPCH: Using Data to Improve Performance – The Clinical Dashboard Presenter: Kevin Clark The.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Systematic Reviews.
Clinical Pharmacy Part 2
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
Grade 9 Drug Education Programme For Cleveland District State High School By Alison Clark.
Mater Emergency Research in Children and Youth Pharmaco-governance of INF use in children in QLD Emergency Departments Amie Lloyd-Jones 4 th Year BPharm.
Amie Lloyd-Jones QUM Project – Mater Children’s Emergency Department (Under supervision of Dr David Herd and Aaron Basing) University of Queensland.
Mater Emergency Research in Children and Youth Pharmaco-governance of INF use in children in QLD Emergency Departments Amie Lloyd-Jones 4 th Year BPharm.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Modelling and Simulation Group, School of Pharmacy Pharmacokinetic/Pharmacodynamic Understanding For Fentanyl IntraNasal in the Paediatric Population Aaron.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Selection of essential medicines Richard Laing and Deidre Dimancesco TBS 2011 Department of Essential Medicines & Pharmaceutical Policies TBS 2008.
Minnesota Manual of Accommodations for Students with Disabilities Training January 2010.
A R ETROSPECTIVE R EVIEW OF THE IMPLEMENTATION OF A VITAMIN D SUPPLEMENTATION POLICY IN CHILDREN WITH CHRONIC RENAL IMPAIRMENT. Sandra H. Geraghty, Clinical.
Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,
Pethidine prescribing in the ED… Let’s be rational! Kaye KI, Maxwell DJ, Graudins L, on behalf of the the NSW Therapeutic Assessment Group (NSW TAG) Drug.
Chapter Dental Public Health & Research Contemporary Practice for the Dental Hygienist Copyright ©2011 by Pearson Education, Inc. All rights reserved.
Off Label Use in Managed Care Pharmacy Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
Standards and Competencies for Cancer Chemotherapy Nursing Practice in Canada: CANO/ACIO AN INTRODUCTION.
© Copyright  People at Work Project - Overview  People at Work Project - Theoretical Underpinnings  People at.
June 2011 Pharmacy Data Management/Drug Databases.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Introduction The majority of telemedicine interactions in Ontario, outside of a hospital, take place among a small number of medical specialities, including.
Methods The initial audit was carried out retrospectively, looking at the acute paediatric presentations from January 2014 to May 2014 inclusive. Patient.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
The transdermal route of delivery has increased in popularity over the past decade with a wide range of medicines now being available [1]. However with.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Off-label Use.
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Enrolling in Clinical Trials
Leigh E. Tenkku, PhD, MPH Department of Family and Community Medicine
Protocol References Section Title 6.2 Entry Visit 5.1
First stages in the HR project
Protocol References Section Title 6.2 Entry Visit 5.1
Reducing Omitted Doses through Audit
Bozeman Health Clinical Research
Clinical audit 2017/18 National Results
Hospital Antibiotic Stewardship Programs
Clinical audit 2017/18 National Results
Chemotherapy Services in England: Ensuring quality and safety
Reducing Omitted Doses through Audit
Evaluation of the Use and Knowledge of Unlicensed Medication
Emergency Laparotomy Cymru
Presentation transcript:

WAR QUM …..What is it good for?

A R EVIEW OF Q UALITY U SE OF M EDICINES (QUM) P ROJECTS AT THE M ATER C HILDREN ’ S E MERGENCY D EPARTMENT

O UTLINE Why a Paediatric Emergency Department Hidden agenda General Discussion of QUM project implementation

B ACKGROUND Mater Children’s Emergency Department, 4-week QUM projects are conducted every 6 months 6 different QUM projects completed in the past two years by UQ pharmacy students By reviewing previous projects and investigating the barriers experienced while carrying out these QUM activities, we can improve the quality process of conducting QUM projects in future and ensuring more sustainable interventions

O BJECTIVES To review previous six QUM projects at the Mater Children’s ED To investigate the limitations from various perspectives while these projects were conducted Make recommendations on how to conduct better QUM projects within the Mater Childrens Emergency Department in future To propose potential QUM research topics for future projects

M ETHODS Review previous projects Interview key stakeholders (directed questions)

T HE 6 QUM P ROJECTS 1. Governance of intranasal Fentanyl in Queensland emergency departments 2. Quality Use of Topical Anaesthetic Medicines in the Mater Children’s Emergency Department 3. Implementation and Maintenance of Buffered Lignocaine Programme in a Children’s Emergency Department 4. Dispensing to patients from Mater Children’s Emergency Department after-hours imprest: risk evaluation 5. Nasal Decongestant strategies in children less than 6 months of age 6. Evaluation of the Suitability of Oral Salbutamol in the Management of Paediatric Asthma

1. G OVERNANCE OF INTRANASAL F ENTANYL IN Q UEENSLAND ED Aim of study : To characterise the use and governance structures surrounding the off-label use of intranasal Fentanyl in children. The Nurse Educators of each eligible ED were asked about the use of intranasal Fentanyl – i.e. the indications, dosing guidelines, inclusion and exclusion criteria of use. It was shown that the off-label use of intranasal Fentanyl in children was being used widely and successfully across Queensland's ED however there were variations in dosing guidelines. This study has demonstrated that it is important for a policy to exist for the use of intranasal Fentanyl in children to ensure safe and effective use. Another recommendation : Nurse initiation of intranasal Fentanyl to reduce time to analgesia safely and effectively following appropriate dosing and administration guidelines.

2. Q UALITY U SE OF T OPICAL A NAESTHETIC M EDICINES IN THE M ATER C HILDREN ’ S ED Aim of study : To evaluate the knowledge of medical and nursing staff in Mater Children's ED regarding the use of topical anaesthetics (EMLA 5% vs amethocaine 4%) for children prior to IV insertion. Methods : Printed survey forms asking perceived minimum age limit for the drug usage, dosage, number and sites of application, duration of application, duration of action and effectiveness. Findings: Staffs were generally more familiar with the use of ELMA compared to amethocaine and also signified evidence-knowledge gap in some aspects. Outcomes/Change to Practice Updated evidence-based policy on the use of topical anaesthetic for children presenting in the Mater Children's ED i.e. lower the age limit for the use of topical anaesthetic in children Posters on the use of different topical anaesthetics

3. I MPLEMENTATION AND M AINTENANCE OF B UFFERED L IGNOCAINE P ROGRAMME IN M ATER C HILDREN ’ S ED This project involved:- Literature review on the beneficial use of buffered lignocaine over conventional acidic lignocaine form developing ways to make buffered lignocaine readily available in the ED implementing procedure to encourage the use of buffered lignocaine in the Children's ED. It was signified in literature that using buffered lignocaine can minimise infiltration pain in children. The outcome of the project had led to change in the department's protocol regarding buffered lignocaine. Posters and reminders to ensure that the buffered lignocaine program has sustainable impact.

4. D ISPENSING TO PATIENTS FROM M ATER C HILDREN ’ S ED AFTER - HOURS IMPREST : RISK EVALUATION Aim of study : To review the use of the imprest medication cupboard at the Mater Children's ED and how prescriptions were written to account for the use of these medications. Conducted interviews with ED staffs on how the cupboard was used and how they think improvements could be made. This study had raised awareness on the way the cupboard is being used not only to the ED staffs but also to the Mater pharmacy department who had been largely uninvolved in this process. It also identified financial issues and risks associated with this process and how they could be addressed.

5. N ASAL D ECONGESTANT STRATEGIES IN CHILDREN LESS THAN 6 MONTHS OF AGE This project involved in:- conducting literature review creating a summary table outlining the current nasal decongestant strategies in children < 6 months of age (including benefits, risks and cost) Emphasised the need to further investigate and validate the clinical choices for decongesting nasal passageways in children < 6 months old to ensure more effective treatment.

6. E VALUATION OF THE S UITABILITY OF O RAL S ALBUTAMOL IN THE M ANAGEMENT OF P AEDIATRIC A STHMA A literature review to determine the safety and efficacy of oral salbutamol in the treatment of children's asthma. Findings: Oral salbutamol is less effective and tolerable than inhaled formulation Hence not recommended in treatment of paediatric asthma. The findings was discussed in a letter to the Medical Journal Australia and in a evidence-based medicine website BestBETs hoping to influence prescriber behaviour and reduce the use of oral salbutamol for paediatric asthma.

R ESULTS S O F AR Common Responses Student responses Earlier ethics approval Earlier contact with preceptor Difficult to interact with ED staff Stakeholders Time Sensitivity See projects as worthwhile

F EEDBACK : What do you think would make a good QUM project? Could you give some ideas that would make QUM placements more meaningful for future pharmacy students?